PAGAN ELEONORA

Vicini, E., Galimberti, V., Leonardi, M., Kahler-Ribeiro-Fontana, S., Polizzi, A., Petitto, S., et al. (2025). Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients. BREAST CANCER RESEARCH AND TREATMENT, 210(3), 661-672 [10.1007/s10549-024-07604-3]. Dettaglio

Pagan, E., Sala, I., Pala, L., Natali, F., Merlo, F., Oriecuia, C., et al. (2025). Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer. JNCI CANCER SPECTRUM, 9(5) [10.1093/jncics/pkaf085]. Dettaglio

Conforti, F., Nekljudova, V., Sala, I., Ascari, R., Solbach, C., Untch, M., et al. (2025). Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer. JOURNAL OF CLINICAL ONCOLOGY, 43(12), 1441-1452 [10.1200/JCO-24-01360]. Dettaglio

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 117(8), 1557-1564 [10.1093/jnci/djaf049]. Dettaglio

Conforti, F., Holtschmidt, J., Nekljudova, V., Sala, I., Pagan, E., Solbach, C., et al. (2025). Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. THE LANCET ONCOLOGY, 26(12), 1584-1597 [10.1016/S1470-2045(25)00546-7]. Dettaglio